282 related articles for article (PubMed ID: 1329257)
1. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
Shimotori T; Sakuragawa N
Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
[TBL] [Abstract][Full Text] [Related]
3. Study of anticoagulant mechanism of low molecular weight heparin.
Hamano S; Nishiyama M; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
Thromb Res; 1992 Mar; 65(6):801-8. PubMed ID: 1321995
[TBL] [Abstract][Full Text] [Related]
4. [Effects of low molecular weight heparin (FR-860) on coagulative and fibrinolytic activities].
Hamano S; Kinukawa M; Komatsu H; Ikeda S; Sakuragawa N
Nihon Yakurigaku Zasshi; 1989 Oct; 94(4):243-9. PubMed ID: 2613105
[TBL] [Abstract][Full Text] [Related]
5. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
6. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
[TBL] [Abstract][Full Text] [Related]
7. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
8. Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis.
Minix R; Doctor VM
Thromb Res; 1997 Sep; 87(5):419-29. PubMed ID: 9306616
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction.
Ockelford PA; Carter CJ; Cerskus A; Smith CA; Hirsh J
Thromb Res; 1982 Sep; 27(6):679-90. PubMed ID: 7179209
[TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic effects of low molecular weight heparin (FR-860) in rabbits].
Hamano S; Komatsu H; Ikeda S; Sakuragawa N
Nihon Yakurigaku Zasshi; 1989 Oct; 94(4):237-42. PubMed ID: 2613104
[TBL] [Abstract][Full Text] [Related]
11. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
12. A comparative study on the mechanism of the anticoagulant action of mollusc and mammalian heparins.
Paiva JF; Santos EA; Jeske W; Fareed J; Nader HB; Dietrich CP
Comp Biochem Physiol A Physiol; 1995 Jul; 111(3):495-9. PubMed ID: 7614042
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
Nagasawa K; Uchiyama H
J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of heparin action.
Jackson CM
Baillieres Clin Haematol; 1990 Jul; 3(3):483-504. PubMed ID: 2176902
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the antithrombotic effect of YM-75466, a novel factor Xa inhibitor, and coagulation parameters in rats.
Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y
Eur J Pharmacol; 1998 Apr; 347(2-3):231-6. PubMed ID: 9653887
[TBL] [Abstract][Full Text] [Related]
16. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
17. Low-affinity material does not contribute to the antithrombotic activity of Orgaran (Org 10172) in human plasma.
Zammit A; Dawes J
Thromb Haemost; 1994 Jun; 71(6):759-67. PubMed ID: 7526481
[TBL] [Abstract][Full Text] [Related]
18. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.
Wall D; Douglas S; Ferro V; Cowden W; Parish C
Thromb Res; 2001 Aug; 103(4):325-35. PubMed ID: 11562342
[TBL] [Abstract][Full Text] [Related]
20. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
